Mar 16, 2016 21:00 pm UTC| Business
Two Late-Breaking Posters Featuring the Company’s Lead Drug Candidate, Selinexor (KPT-330), and Second Generation SINE Compound KPT-8602 Seventeen Additional Poster Presentations Highlighting Key Scientific Findings for...
Protea Announces 2015 Year End Results
Mar 16, 2016 21:00 pm UTC| Business
MORGANTOWN, W.Va., March 16, 2016 -- Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”) released its FY2015 results today, reporting total revenue of $2,003,286, an increase of 13% over FY2014 revenue of $1,768,312....
QIWI Announces Extraordinary General Meeting of Shareholders
Mar 16, 2016 21:00 pm UTC| Business
NICOSIA, Cyprus, March 16, 2016 -- QIWI plc (Nasdaq:QIWI) (MOEX:QIWI) ("QIWI" or the "Company") today announced that it will hold an extraordinary general meeting of shareholders ("EGM") on Friday April 29, 2016, at...
Mar 16, 2016 20:55 pm UTC| Business
SANTA MONICA, Calif., March 16, 2016 -- Kite Pharma, Inc., (Nasdaq:KITE) (“Kite”) a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment...
Intuitive Surgical Reports New Employee Option Grants for March 2016
Mar 16, 2016 20:46 pm UTC| Business
SUNNYVALE, Calif., March 16, 2016 -- Intuitive Surgical, Inc. (Nasdaq:ISRG) today reported that equity awards approved by the Compensation Committee of the Board of Directors, which consists entirely of Independent...
Jounce Therapeutics to Present Program Updates at AACR Annual Meeting 2016
Mar 16, 2016 20:46 pm UTC| Business
CAMBRIDGE, Mass., March 16, 2016 -- Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies coupled to patient enrichment strategies, today announced that advances...
Mar 16, 2016 20:45 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 16, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases...